1. Home
  2. CDXS

CDXS

Codexis Inc.

Logo Codexis Inc.

Industrials

Major Chemicals

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products, leveraging its proprietary CodeEvolver directed evolution technology platform. The firm's products and services include Biocatalysts and Enzymes. The company generates majority of its revenue through product sales and also licenses its technology platform CodeEvolver to pharmaceutical companies enabling them to use this technology, in-house, to engineer enzymes for their own businesses. Geographically, it derives revenue from the United States, Ireland, Switzerland, China and other markets.

Founded: 2002 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 224.3M IPO Year: 2010
Target Price: $7.50 AVG Volume (30 days): 587.2K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.12 EPS Growth: N/A
52 Week Low/High: $1.45 - $4.91 Next Earning Date: 05-02-2024
Revenue: $70,143,000 Revenue Growth: -49.39%
Revenue Growth (this year): -4.92% Revenue Growth (next year): -5.09%

Share on Social Networks: